Is LGN a Buy? What to Consider in 2026
Short answer
The bull case for Legence Corp (LGN) rests on Data center and AI infrastructure demand: Technical cooling and complex MEP systems for hyperscale and colocation data centers are Legence's primary growth driver. Revenue (TTM) is ~$3.08B. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: Growth is heavily tied to the data center capital cycle, so any slowdown in AI or hyperscaler spending would hit backlog and revenue hard. Whether LGN is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.
Legence Corp (NASDAQ: LGN) designs, installs, and maintains the mechanical, electrical, plumbing (MEP), and energy systems that keep technically demanding buildings running, operating through Engineering & Consulting and Installation & Maintenance segments. More than half its revenue now comes from what it calls high-growth end markets, chiefly data centers and technology plus life sciences and healthcare, where it provides technical cooling and complex process systems. The company went public in September 2025 at $28 per share and remains majority-controlled by Blackstone, which retained roughly 74 percent of voting power after the IPO. The investment picture is a growth-industrials story tied to the AI and data center capital cycle. Revenue is expanding rapidly (trailing twelve-month revenue around $3.08 billion, up roughly 44 percent, with Q1 2026 revenue near $1.04 billion, up about 105 percent year over year) and backlog has more than doubled, giving multi-year visibility. The offset is that GAAP net income is still thin (near breakeven on a trailing basis) despite improving adjusted EBITDA margins, the stock trades at a premium after more than doubling from its IPO price, and Blackstone's control plus a competitive MEP field temper the case.
What's the case for buying LGN?
1. Data center and AI infrastructure demand
Technical cooling and complex MEP systems for hyperscale and colocation data centers are Legence's primary growth driver. Some fabrication orders now extend into late 2028, and management points to a large multi-year pipeline as AI compute buildout accelerates. This is the single biggest reason revenue and backlog are compounding so fast.
2. Record backlog and raised guidance
Total backlog and awards reached roughly $5.38 billion in Q1 2026, more than double a year earlier, with a book-to-bill above 1x. Management raised full-year 2026 revenue guidance to about $4.1 billion to $4.3 billion and adjusted EBITDA to roughly $470 million to $490 million, signaling confidence in near-term execution.
3. Energy efficiency and decarbonization services
Beyond new construction, Legence sells energy audits, retrofits, and sustainability strategies that help owners cut building energy use. This higher-margin, recurring-flavored work broadens the revenue base beyond one-off installs and aligns with corporate decarbonization budgets and efficiency mandates.
4. Acquisition-led scale and margin expansion
Legence has grown partly through M&A (including the Bowers acquisition), rolling up regional MEP and engineering firms to add capacity and geographic reach. Adjusted EBITDA margin has been climbing (around 11.4 percent in Q1 2026), suggesting operating leverage as volume scales, though acquisitions also add integration and leverage risk.
What are the risks to LGN?
Growth is heavily tied to the data center capital cycle, so any slowdown in AI or hyperscaler spending would hit backlog and revenue hard. GAAP profitability remains thin (trailing net income near breakeven despite strong revenue and adjusted EBITDA), and the stock trades at a premium after more than doubling from its September 2025 IPO price, leaving little room for execution missteps. Blackstone retains roughly 74 percent of voting control, so public shareholders have limited say and face potential future share sales that could pressure the price. The MEP services market is competitive and cyclical, with larger and well-capitalized rivals, and acquisition-driven growth carries integration and balance-sheet risk. Project-based construction revenue can also be lumpy and exposed to labor availability, input costs, and macro construction demand.
How is LGN valued? (as of JULY 2026)
Snapshot for LGN as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Share price: ~$70
- Market cap: ~$7.6B
- Revenue (TTM): ~$3.08B
- Revenue growth (TTM): ~44%
- Q1 2026 adj. EBITDA: ~$118M (~11.4% margin)
- Total backlog and awards: ~$5.38B
As of July 2026 Legence trades around $70 per share, roughly two and a half times its $28 September 2025 IPO price, for a market cap near $7.6 billion against trailing revenue of about $3.08 billion. GAAP net income is still thin (near breakeven on a trailing basis), so the market is valuing the company on rapid revenue growth, an expanding adjusted EBITDA margin, and a backlog that has more than doubled year over year. Management raised full-year 2026 guidance to roughly $4.1 billion to $4.3 billion in revenue and $470 million to $490 million in adjusted EBITDA.
How do you decide if LGN is a buy?
Rather than asking whether LGN is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold LGN indirectly through an index or sector ETF before adding more.
For the full picture, see the LGN stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about LGN against your real portfolio and see your actual exposure before deciding.
The bottom line on LGN
The bottom line: Legence Corp's story right now is Data center and AI infrastructure demand, with revenue (ttm) at ~$3.08B. If you believe that narrative continues, the call is about sizing LGN sensibly and checking overlap with what you own; if you doubt it (the risk: growth is heavily tied to the data center capital cycle, so any slowdown in AI or hyperscaler spending would hit backlog and revenue hard.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.
Build a basket around LGN with Walnut
Use Legence Corp as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Is LGN a good stock to buy right now?
+
The case for Legence Corp right now is Data center and AI infrastructure demand, with revenue (ttm) at ~$3.08B. If you believe that thesis holds, LGN is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is growth is heavily tied to the data center capital cycle, so any slowdown in AI or hyperscaler spending would hit backlog and revenue hard. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.
What does Legence Corp do?
+
Legence Corp (NASDAQ: LGN) designs, installs, and maintains the mechanical, electrical, plumbing (MEP), and energy systems that keep technically demanding buildings running, operat
What are the main risks of LGN?
+
Growth is heavily tied to the data center capital cycle, so any slowdown in AI or hyperscaler spending would hit backlog and revenue hard. GAAP profitability remains thin (trailing net income near breakeven despite strong revenue and adjusted EBITDA), and the stock trades at a premium after more than doubling from its September 2025 IPO price, leaving little room for execution missteps. Blackstone retains roughly 74 percent of voting control, so public shareholders have limited say and face potential future share sales that could pressure the price. The MEP services market is competitive and cyclical, with larger and well-capitalized rivals, and acquisition-driven growth carries integration and balance-sheet risk. Project-based construction revenue can also be lumpy and exposed to labor availability, input costs, and macro construction demand.
What does Legence Corp (LGN) do?
+
Legence provides engineering, installation, and maintenance for mission-critical building systems, including HVAC, mechanical, electrical, and plumbing (MEP) work plus energy-efficiency services. It runs Engineering & Consulting and Installation & Maintenance segments and serves data centers, technology, life sciences, and healthcare buildings.
Is LGN the same as Ligand Pharmaceuticals?
+
No. Ligand Pharmaceuticals trades under LGND. LGN is Legence Corp, an industrials company focused on building systems and MEP services. The tickers are easy to confuse, so double-check LGN versus LGND before acting.
When did Legence go public?
+
Legence completed its IPO on the Nasdaq Global Select Market on September 12, 2025, pricing 26 million Class A shares at $28.00 each and raising roughly $728 million. It debuted at a valuation near $3.2 billion.
Why is Legence growing so fast?
+
Demand for data center and AI infrastructure is the main driver. Legence builds the technical cooling and MEP systems those facilities need, pushing trailing revenue up around 44 percent and lifting backlog past $5 billion as of Q1 2026, with some orders extending into 2028.
Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell LGN; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.